CCNO and glioblastoma: Our findings match prior data by others, in which GBM cells derived from post-TMZ, MMR-mutant patient tumors were TMZ resistant but sensitive to CCNU, and TMZ-naïve GBM cells with artificial MMR gene inactivation acquired TMZ resistance while remaining sensitive to CCNU [10].